The company recently canceled its Q2 earnings call and had hoped to file financials by Oct. 15, but officials said Tuesday that it's not going to happen. 

U.S. healthcare will soon welcome the country’s first hospital department focused on applying AI to biomedical research and clinical medicine

FDA could do more to police regulated products for algorithmic biases that may affect clinical outcomes in vulnerable subpopulations.

Under a five-year pact, the New Zealand-based firm will install patient-tracking software across a network of imaging centers spanning 11 states.

Not much M&A activity has occurred in healthcare during the third quarter of 2021, but a few recently announced deals are big in value. 

That's the second most expensive service item contributing to cancer's $156.2 billion price tag in 2018, experts reported Wednesday in JAMA Network Open.

For Boston Scientific, the acquisition will add new left heart access platforms to its electrophysiology and structural heart portfolios.

Opponents believe the $13B merger deal will give UHC access to a trove of intelligence on physicians, which it could wield unfairly in rate negotiations.